• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 感染者的银屑病与肝损伤

Psoriasis and Liver Damage in HIV-Infected Patients.

机构信息

HIV Unit. Department of Internal Medicine, La Paz University Hospital, 28046 Madrid, Spain.

Department of Dermatology, La Paz University Hospital, 28046 Madrid, Spain.

出版信息

Cells. 2021 May 4;10(5):1099. doi: 10.3390/cells10051099.

DOI:10.3390/cells10051099
PMID:34064387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8147812/
Abstract

: Psoriasis is the most frequent skin disease in HIV-infected patients. Nonalcohol fatty liver disease (NAFLD) is more prevalent in patients with psoriasis. We report the prevalence of psoriasis and NAFLD and investigate risk factors of liver damage in HIV-infected patients with psoriasis. : We performed a retrospective observational study. Steatosis was defined as indicative abdominal ultrasound findings, CAP (controlled attenuated parameter by transient elastography) > 238 dB/m, and/or triglyceride and glucose index (TyG) > 8.38. Significant (fibrosis ≥ 2) and advanced liver fibrosis (fibrosis ≤ F3) were studied by transient elastography (TE) and/or FIB-4 using standard cutoff points. FIB-4 (Fibrosis 4 score) results were adjusted for hepatitis C (HCV)-coinfected patients. : We identified 80 patients with psoriasis (prevalence, 1.5%; 95% CI, 1.1-1.8). Psoriasis was severe (PASI > 10 and/or psoriatic arthritis) in 27.5% of cases. The prevalence of steatosis was 72.5% (95% CI, 65-85). Severe psoriasis was an independent risk factor for steatosis (OR, 12; 95% CI, 1.2-120; = 0.03). Significant liver fibrosis ( < 0.05) was associated with HCV coinfection (OR 3.4; 95% CI, 1.1-10.6), total CD4 (OR 0.99; 95% CI, 0.99-1), and time of efavirenz exposure (OR 1.2; 95% CI, 1.0-1.3). : The prevalence of psoriasis in HIV-infected patients was similar to that of the general population. Steatosis is highly prevalent, and severe psoriasis is an independent risk factor for steatosis in HIV-infected patients.

摘要

: 银屑病是 HIV 感染者中最常见的皮肤疾病。非酒精性脂肪性肝病(NAFLD)在银屑病患者中更为普遍。我们报告了 HIV 感染者中银屑病和 NAFLD 的患病率,并调查了银屑病 HIV 感染者肝损伤的危险因素。 : 我们进行了一项回顾性观察性研究。脂肪肝定义为腹部超声有提示性表现、受控衰减参数(CAP)>238dB/m 和/或甘油三酯和葡萄糖指数(TyG)>8.38。通过瞬时弹性成像(TE)和/或使用标准截断值的 FIB-4 研究显著(纤维化≥2)和晚期肝纤维化(纤维化≤F3)。FIB-4(纤维化 4 评分)结果针对丙型肝炎病毒(HCV)合并感染患者进行了调整。 : 我们共确定了 80 例银屑病患者(患病率为 1.5%;95%可信区间为 1.1-1.8)。27.5%的病例中银屑病严重(PASI>10 和/或银屑病关节炎)。脂肪肝的患病率为 72.5%(95%可信区间为 65-85)。严重银屑病是脂肪肝的独立危险因素(OR,12;95%可信区间,1.2-120; =0.03)。显著的肝纤维化( < 0.05)与 HCV 合并感染(OR 3.4;95%可信区间,1.1-10.6)、总 CD4(OR 0.99;95%可信区间,0.99-1)和依非韦伦暴露时间(OR 1.2;95%可信区间,1.0-1.3)有关。 : HIV 感染者中银屑病的患病率与一般人群相似。脂肪肝患病率很高,严重银屑病是 HIV 感染者中脂肪肝的独立危险因素。

相似文献

1
Psoriasis and Liver Damage in HIV-Infected Patients.HIV 感染者的银屑病与肝损伤
Cells. 2021 May 4;10(5):1099. doi: 10.3390/cells10051099.
2
Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.代谢综合征、非酒精性脂肪性肝病与银屑病关节炎及银屑病患者的肝硬度。
Clin Rheumatol. 2019 Oct;38(10):2843-2850. doi: 10.1007/s10067-019-04646-7. Epub 2019 Jun 28.
3
Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients.在未经过挑选的单纯HIV感染患者中,通过瞬时弹性成像联合受控衰减参数诊断非酒精性脂肪性肝病。
AIDS. 2016 Nov 13;30(17):2635-2643. doi: 10.1097/QAD.0000000000001241.
4
Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.HIV 单一感染患者的肝脂肪变性比 HIV/HCV 合并感染患者进展更快,且与肝纤维化相关。
J Hepatol. 2017 Oct;67(4):801-808. doi: 10.1016/j.jhep.2017.05.011. Epub 2017 May 18.
5
Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients.非侵入性评估 HIV/HCV 和 HCV 感染患者的肝脂肪变性和纤维化。
Ann Hepatol. 2013 Sep-Oct;12(5):740-8.
6
Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy.长期联合抗逆转录病毒治疗的 HIV 单感染患者通过瞬时弹性成像预测肝纤维化和脂肪变性的相关因素。
J Int AIDS Soc. 2018 Nov;21(11):e25201. doi: 10.1002/jia2.25201.
7
Diagnostic value of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV.用于检测 HIV 感染者非酒精性脂肪性肝病(NAFLD)和/或肝纤维化的血清学生物标志物的诊断价值。
HIV Med. 2021 Jul;22(6):445-456. doi: 10.1111/hiv.13060. Epub 2021 Feb 2.
8
Transient Elastography in HIV Infected Patients with Liver Steatosis Identifies a High-Risk Group for Non-Alcoholic Steatohepatitis.瞬时弹性成像技术在合并肝脂肪变性的HIV感染患者中识别出非酒精性脂肪性肝炎的高危人群。
Curr HIV Res. 2021;19(4):311-316. doi: 10.2174/1570162X19666210225085002.
9
Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus.肝脂肪变对 HIV/HCV 合并感染患者肝瞬时弹性成像检测的肝硬度与纤维化相关性的影响。
J Viral Hepat. 2011 Jul;18(7):e278-83. doi: 10.1111/j.1365-2893.2010.01407.x. Epub 2010 Dec 3.
10
Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?银屑病中肝脏硬度测量:代谢因素还是疾病因素起重要作用?
Biomed Res Int. 2016;2016:7963972. doi: 10.1155/2016/7963972. Epub 2016 Feb 23.

引用本文的文献

1
Risk Factors Related to the Development of Nonalcoholic Fatty Liver: A Systematic Review.与非酒精性脂肪肝发生相关的危险因素:一项系统评价
Can J Gastroenterol Hepatol. 2025 Apr 15;2025:9964486. doi: 10.1155/cjgh/9964486. eCollection 2025.
2
Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review.银屑病的流行病学和合并症:一篇叙述性综述。
Front Immunol. 2022 Jun 10;13:880201. doi: 10.3389/fimmu.2022.880201. eCollection 2022.

本文引用的文献

1
Psoriasis and fatty liver: a harmful synergy.银屑病与脂肪肝:有害的协同作用。
Rev Esp Enferm Dig. 2019 Apr;111(4):314-319. doi: 10.17235/reed.2019.6263/2019.
2
HIV-Associated Psoriasis.艾滋病相关银屑病
Actas Dermosifiliogr (Engl Ed). 2018 May;109(4):303-311. doi: 10.1016/j.ad.2017.09.014. Epub 2018 Feb 1.
3
Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults.在肥胖的 HIV 感染成年人中,受控衰减参数和磁共振波谱测量的肝脂肪变性不一致。
AIDS. 2017 Sep 24;31(15):2119-2125. doi: 10.1097/QAD.0000000000001601.
4
HIV Infection Increases the Risk of Incident Psoriasis: A Nationwide Population-Based Cohort Study in Taiwan.HIV感染会增加患银屑病的风险:台湾一项基于全国人口的队列研究
J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):493-499. doi: 10.1097/QAI.0000000000001431.
5
Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects.依非韦伦:关于其不良反应的细胞机制有哪些已知信息。
Eur J Pharmacol. 2017 Oct 5;812:163-173. doi: 10.1016/j.ejphar.2017.07.016. Epub 2017 Jul 8.
6
Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection.人类免疫缺陷病毒单一感染中非酒精性脂肪性肝病的患病率及危险因素
AIDS. 2017 Jul 17;31(11):1621-1632. doi: 10.1097/QAD.0000000000001504.
7
Liver fibrosis and fatty liver in Asian HIV-infected patients.亚洲 HIV 感染者的肝纤维化和脂肪肝。
Aliment Pharmacol Ther. 2016 Aug;44(4):411-21. doi: 10.1111/apt.13702. Epub 2016 Jun 15.
8
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background.银屑病、非酒精性脂肪性肝病和心血管疾病:独特背景下的三种不同疾病。
World J Cardiol. 2016 Feb 26;8(2):120-31. doi: 10.4330/wjc.v8.i2.120.
9
Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.银屑病患者非酒精性脂肪性肝病的风险:一项系统评价和荟萃分析。
J Eur Acad Dermatol Venereol. 2015 Apr;29(4):656-62. doi: 10.1111/jdv.12847. Epub 2014 Nov 21.
10
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者脂肪变性生物标志物的性能与局限性
Aliment Pharmacol Ther. 2014 Nov;40(10):1209-22. doi: 10.1111/apt.12963. Epub 2014 Sep 29.